HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#181 / 200 Total
PACB - Pacific Biosciences of California Inc - Stock Price Chart
TickerPACB [NASD, RUT]
CompanyPacific Biosciences of California Inc
CountryUSA
IndustryMedical Devices
Market Cap480.14MEPS (ttm)-2.77
P/E-EPS this Y6.94%
Forward P/E-EPS next Y48.37%
PEG-EPS past 5Y-23.55%
P/S3.15EPS next 5Y27.35%
P/B5.24EPS Q/Q-394.93%
Dividend-Sales Q/Q-4.27%
Insider Own11.97%Inst Own65.85%
Insider Trans-1.23%Inst Trans-12.68%
Short Float15.01%EarningsMay 08/a
Analyst Recom2.21Target Price1.96
Avg Volume9.40M52W Range0.85 - 2.72
Jul-03-25 09:08AM Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue (Insider Monkey) +7.38%
Jun-30-25 06:15PM Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:50AM The 5 Most Interesting Analyst Questions From PacBio's Q1 Earnings Call (StockStory)
Jun-13-25 11:30AM Why Is Steris (STE) Down 1.8% Since Last Earnings Report? (Zacks)
Jun-12-25 06:15PM Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know (Zacks)
Jun-10-25 06:41AM PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds (StockStory)
Jun-05-25 12:07PM Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jun-04-25 11:31PM Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment (StockStory)
Jun-02-25 10:00AM Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date (PR Newswire)
May-29-25 12:00PM All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy (Zacks) -5.45%
ADGM - Adagio Medical Holdings Inc - Stock Price Chart
TickerADGM [NASD]
CompanyAdagio Medical Holdings Inc
CountryUSA
IndustryMedical Devices
Market Cap23.84MEPS (ttm)-11.04
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-816.44%
P/S41.10EPS next 5Y-
P/B1.92EPS Q/Q95.12%
Dividend-Sales Q/Q-100.00%
Insider Own1.81%Inst Own75.37%
Insider Trans0.00%Inst Trans64.23%
Short Float1.19%Earnings-
Analyst Recom-Target Price-
Avg Volume2.02M52W Range0.62 - 11.57
May-15-25 04:05PM Adagio Medical Reports First Quarter 2025 Results (Business Wire)
May-07-25 08:30AM Adagio Medical to Present at the BofA Securities 2025 Health Care Conference (Business Wire)
Apr-17-25 08:30AM Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System (Business Wire) +92.81%
Mar-31-25 04:01PM Adagio Medical Appoints Deborah Kaster as Chief Business Officer (Business Wire) -14.36%
08:30AM Adagio Medical Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Mar-17-25 04:01PM Adagio Medical Provides Clinical and Business Updates (Business Wire) -7.41% -9.00%
Feb-28-25 08:30AM Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation (Business Wire) -45.94%
Feb-18-25 04:01PM Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference (Business Wire)
Dec-16-24 08:00AM Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director (Business Wire) -9.41%
Nov-14-24 04:01PM Adagio Medical Reports Third Quarter 2024 Results (Business Wire) +57.87% -19.14%
MEIP - MEI Pharma Inc - Stock Price Chart
TickerMEIP [NASD]
CompanyMEI Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap17.86MEPS (ttm)-4.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.91EPS Q/Q71.81%
Dividend-Sales Q/Q-
Insider Own1.31%Inst Own40.06%
Insider Trans0.00%Inst Trans-3.32%
Short Float0.02%EarningsMay 13/a
Analyst Recom2.33Target Price22.67
Avg Volume12.90K52W Range1.46 - 4.10
May-13-25 04:05PM MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position (Business Wire) +6.22%
Mar-26-25 08:00AM The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors (Business Wire)
Feb-12-25 04:12PM MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position (Business Wire)
Nov-12-24 04:05PM MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position (Business Wire)
Sep-19-24 04:01PM MEI Pharma Reports Fiscal Year End 2024 Cash Position (Business Wire) -5.10%
Aug-12-24 08:30AM MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives (Business Wire)
Jul-22-24 08:30AM MEI Pharma to Consider Strategic Alternatives (Business Wire) +21.33%
Jul-01-24 02:18PM 7 Undervalued Biotech Stocks to Buy for Big-Time Returns (InvestorPlace)
May-09-24 10:57PM MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024 (InvestorPlace)
04:02PM MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights (Business Wire)
AGEN - Agenus Inc - Stock Price Chart
TickerAGEN [NASD, RUT]
CompanyAgenus Inc
CountryUSA
IndustryBiotechnology
Market Cap166.42MEPS (ttm)-8.68
P/E-EPS this Y74.98%
Forward P/E6.04EPS next Y137.92%
PEG-EPS past 5Y7.90%
P/S1.67EPS next 5Y38.34%
P/B-EPS Q/Q65.97%
Dividend-Sales Q/Q-14.07%
Insider Own4.39%Inst Own31.90%
Insider Trans0.00%Inst Trans12.25%
Short Float12.27%EarningsMay 12/b
Analyst Recom2.20Target Price11.50
Avg Volume1.12M52W Range1.38 - 18.74
Jul-02-25 10:32AM Apellis Stock Rises on $300M Royalty Deal With Sobi for Aspaveli (Zacks) +13.84%
Jul-01-25 10:50AM Biogen Begins Phase III Felzartamab Study for Third Kidney Disease (Zacks) +5.91%
09:17AM Moderna Stock Gains on Encouraging Flu Vaccine Data (Zacks)
Jun-30-25 11:40AM RARE's GTX-102 Gets FDA's Breakthrough Status for Angelman Syndrome (Zacks)
Jun-27-25 09:40AM Are Medical Stocks Lagging CVS Health (CVS) This Year? (Zacks)
Jun-25-25 11:17AM KRYS Up 4% on Initiating Dosing in Rare Eye Disease Phase III Study (Zacks)
11:06AM Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU (Zacks)
10:02AM Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag (Zacks)
Jun-24-25 11:58AM CHMP Backs NVO's Ozempic EU Label Update for Cardiovascular Indication (Zacks)
09:04AM FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer (Zacks)
SWIN - Solowin Holdings - Stock Price Chart
TickerSWIN [NASD]
CompanySolowin Holdings
CountryHong Kong
IndustryCapital Markets
Market Cap219.21MEPS (ttm)-0.05
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-118.12%
P/S608.92EPS next 5Y-
P/B104.07EPS Q/Q33.83%
Dividend-Sales Q/Q7.39%
Insider Own73.23%Inst Own0.08%
Insider Trans0.00%Inst Trans-45.74%
Short Float0.25%Earnings-
Analyst Recom-Target Price-
Avg Volume182.26K52W Range1.16 - 3.69
Jan-03-25 05:00PM Solowin and Partners Invest US$10M in AlloyX's Pre-A Funding Round (GlobeNewswire) -6.77% +31.72%
Dec-31-24 04:30PM SOLOWIN HOLDINGS Reports Unaudited Financial Results for The First Six Months of Fiscal Year 2025 (PR Newswire) +14.58% +20.91%
Dec-26-24 08:00AM Solowin Announces Participation in HKMA's Project Ensemble Sandbox to Jointly Promote the Development of Hong Kong's Tokenization Market (GlobeNewswire) +11.63%
Nov-29-24 08:00AM Horizon Partners with SOLOWIN to Deliver Enhanced OMS and Algo Solutions (GlobeNewswire) +6.63%
Nov-21-24 08:00AM SOLOWIN Signs Strategic Partnership with Zodia Custody to Facilitate Hong Kong's Digital Asset Ecosystem (GlobeNewswire)
Oct-23-24 04:30PM SOLOWIN HOLDINGS Announces New Equity Research Report from Diamond Equity Research (GlobeNewswire) -5.42%
Oct-21-24 08:00AM Diamond Equity Research Initiates Coverage on Solowin Holdings (NASDAQ:SWIN) (GlobeNewswire)
Jun-17-24 08:00AM SOLOWIN Driving Investor Adoption of Virtual Assets as the Largest Holder of Multiple Spot Bitcoin and Ethereum ETFs in Hong Kong (GlobeNewswire) +7.14%
May-28-24 08:00AM Solowin Announces Strategic Partnership with MaiCapital to Expand Virtual Asset Allocation Opportunities (GlobeNewswire) -10.68%
May-24-24 07:16AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -25.97%
XPOF - Xponential Fitness Inc - Stock Price Chart
TickerXPOF [NYSE, RUT]
CompanyXponential Fitness Inc
CountryUSA
IndustryLeisure
Market Cap490.00MEPS (ttm)-2.03
P/E-EPS this Y624.18%
Forward P/E7.07EPS next Y109.64%
PEG-EPS past 5Y-
P/S1.55EPS next 5Y-
P/B-EPS Q/Q68.20%
Dividend-Sales Q/Q-3.32%
Insider Own23.94%Inst Own83.18%
Insider Trans0.00%Inst Trans-3.99%
Short Float10.50%EarningsMay 08/a
Analyst Recom1.89Target Price13.78
Avg Volume658.59K52W Range6.64 - 18.95
Today 09:06AM Xponential Fitness (XPOF) Soars 35.4%: Is Further Upside Left in the Stock? (Zacks)
01:30AM 5 Must-Read Analyst Questions From Xponential Fitness's Q1 Earnings Call (StockStory)
Jul-03-25 12:50PM Why Is Xponential Fitness (XPOF) Stock Soaring Today (StockStory) +35.39%
Jun-22-25 11:34PM Leisure Facilities Stocks Q1 Recap: Benchmarking Xponential Fitness (NYSE:XPOF) (StockStory)
Jun-17-25 09:00AM Xponential Fitness, Inc. Appoints Lily Yang to its Board of Directors (Business Wire) -5.66%
Jun-12-25 10:02AM PTON Stock Rises 22% in 3 Months: Should You Buy Now or Hold Steady? (Zacks)
Jun-02-25 11:29AM Planet Fitness Up 11% in Three Months: Should You Buy, Sell or Hold? (Zacks)
May-29-25 08:55AM NYSE Content Advisory: Pre-Market update + Nvidia, Salesforce beat on earnings (PR Newswire) +5.95%
May-28-25 04:05PM Xponential Fitness, Inc. to Host Analyst and Investor Day Tomorrow (Business Wire)
May-21-25 12:36AM 3 Russell 2000 Stocks with Mounting Challenges (StockStory)
VYNE - VYNE Therapeutics Inc - Stock Price Chart
TickerVYNE [NASD]
CompanyVYNE Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap23.75MEPS (ttm)-0.99
P/E-EPS this Y-10.22%
Forward P/E-EPS next Y28.29%
PEG-EPS past 5Y65.87%
P/S39.58EPS next 5Y11.71%
P/B0.52EPS Q/Q-37.65%
Dividend-Sales Q/Q106.12%
Insider Own18.32%Inst Own36.72%
Insider Trans0.49%Inst Trans1.45%
Short Float2.53%EarningsMay 08/b
Analyst Recom1.00Target Price6.38
Avg Volume556.36K52W Range0.85 - 4.30
Jul-02-25 07:45AM VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202 (GlobeNewswire) -14.69%
May-08-25 08:00AM VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update (GlobeNewswire) -5.11%
Apr-25-25 08:00AM VYNE Therapeutics Provides Update on VYN202 Program (GlobeNewswire) -23.94%
Mar-20-25 08:00AM VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference (GlobeNewswire) -5.08%
Mar-06-25 08:00AM VYNE Therapeutics Reports 2024 Fourth Quarter and Year-End Financial Results and Provides Business Update (GlobeNewswire)
Feb-20-25 08:00AM VYNE Therapeutics to Participate in March Investor Conferences (GlobeNewswire) +7.14%
Feb-19-25 08:00AM VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis (GlobeNewswire)
Jan-06-25 07:30AM VYNE Therapeutics Completes Enrollment in Phase 2b Trial Evaluating VYN201 for the Treatment of Nonsegmental Vitiligo (GlobeNewswire) +15.61%
Dec-24-24 09:51AM H.C. Wainwright says VYNEs VYN202 becomes pick of the crop after MAD data (TipRanks) +15.56%
Dec-23-24 07:30AM VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor (GlobeNewswire)
SYM - Symbotic Inc - Stock Price Chart
TickerSYM [NASD]
CompanySymbotic Inc
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap28.25BEPS (ttm)-0.07
P/E-EPS this Y72.98%
Forward P/E113.58EPS next Y103.21%
PEG-EPS past 5Y-415.28%
P/S13.56EPS next 5Y73.59%
P/B25.28EPS Q/Q58.16%
Dividend-Sales Q/Q39.74%
Insider Own59.04%Inst Own37.07%
Insider Trans-0.05%Inst Trans0.17%
Short Float36.17%EarningsMay 07/a
Analyst Recom2.06Target Price33.33
Avg Volume1.66M52W Range16.32 - 42.79
Jul-03-25 07:46PM Why Symbotic Stock Skyrocketed Again Today (Motley Fool) +13.53%
09:00AM Symbotic Inc. (SYM) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jul-02-25 11:52AM Warehouse Automation Trend Is Positive For These Stocks (Investor's Business Daily) +6.35%
11:25AM This is the Stock I'm Retiring On - It's Already Up 70% (Insider Monkey)
Jul-01-25 06:00PM Symbotic Inc. (SYM) Ascends While Market Falls: Some Facts to Note (Zacks)
04:21PM Why Symbotic is the better robotics pick not Tesla (Yahoo Finance Video)
Jun-30-25 12:22PM These 5 Stocks Will Replace Your Job (Insider Monkey)
Jun-25-25 05:21PM Why Symbotic Stock Soared Today (Motley Fool) +8.42% +6.45%
Jun-23-25 06:15PM Symbotic Inc. (SYM) Stock Dips While Market Gains: Key Facts (Zacks)
Jun-21-25 07:00AM Is It Too Late to Buy Symbotic Stock? (Motley Fool)
LSE - Leishen Energy Holding Co Ltd - Stock Price Chart
TickerLSE [NASD]
CompanyLeishen Energy Holding Co Ltd
CountryChina
IndustryOil & Gas Equipment & Services
Market Cap103.82MEPS (ttm)0.48
P/E12.72EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.50EPS next 5Y-
P/B2.59EPS Q/Q-61.97%
Dividend-Sales Q/Q-33.44%
Insider Own91.04%Inst Own0.07%
Insider Trans0.00%Inst Trans6.24%
Short Float0.25%EarningsFeb 18/b
Analyst Recom-Target Price-
Avg Volume448.47K52W Range3.76 - 14.99
Apr-24-25 07:25AM Why Leishen Energy Holding (LSE) Is Losing This Week (Insider Monkey)
Apr-07-25 06:10AM Leishen Energy Holding Co., Ltd is trying to make a strategic layout in Middle East as a production base for overseas market (GlobeNewswire)
Mar-26-25 09:32PM Why Leishen Energy Holding Co., Ltd. (LSE) is Gaining This Week? (InsiderMonkey)
Mar-21-25 07:06AM Why Leishen Energy Holding Co., Ltd. (LSE) Went Down On Thursday? (InsiderMonkey) -19.83%
Feb-18-25 09:30AM Leishen Energy Holding Co., Ltd. Announces Fiscal Year 2024 Financial Results Highlighting Strong Operating Cash Flow and Stable Gross Margins (GlobeNewswire)
Feb-03-25 01:45PM Why Leishen Energy Holding Co., Ltd. (LSE) is Skyrocketing So Far In 2025? (Insider Monkey) +11.24%
Jan-08-25 04:30PM Leishen Energy Holding Co., Ltd. Announces Partial Exercise of the Underwriters' Over-Allotment Option in Connection with its Initial Public Offering (GlobeNewswire) -5.04% +9.04%
Dec-20-24 12:20PM Leishen Energy Holding Co., Ltd. Announces Closing of $5,500,000 Initial Public Offering (GlobeNewswire) +14.48%
Dec-18-24 09:26PM Leishen Energy Holding Co., Ltd. Prices $5,500,000 Initial Public Offering (GlobeNewswire)
PYXS - Pyxis Oncology Inc - Stock Price Chart
TickerPYXS [NASD, RUT]
CompanyPyxis Oncology Inc
CountryUSA
IndustryBiotechnology
Market Cap68.14MEPS (ttm)-1.58
P/E-EPS this Y-4.29%
Forward P/E-EPS next Y13.20%
PEG-EPS past 5Y-74.92%
P/S-EPS next 5Y2.24%
P/B0.66EPS Q/Q-445.83%
Dividend-Sales Q/Q-100.00%
Insider Own28.94%Inst Own39.14%
Insider Trans0.00%Inst Trans-4.54%
Short Float14.04%EarningsMay 15/b
Analyst Recom1.33Target Price6.20
Avg Volume565.80K52W Range0.83 - 5.39
Jun-30-25 04:30PM Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-15-25 07:00AM Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
May-14-25 07:30AM Pyxis Oncology to Participate in Two Upcoming Investor Conferences (GlobeNewswire) -10.08%
Apr-25-25 01:17PM Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC (GlobeNewswire)
Apr-24-25 08:56AM Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics (Zacks)
Apr-23-25 09:32AM 5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms (Zacks) +5.88%
Apr-16-25 09:45AM Top Cancer Stocks to Buy to Boost Your Portfolio's Health (Zacks)
Apr-02-25 07:30AM Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum (GlobeNewswire) +11.48%
Mar-25-25 04:30PM Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025 (GlobeNewswire) -8.70%
Mar-18-25 07:30AM Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (GlobeNewswire) -8.62%
1⋯10⋯14151617181920
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.